Aspirin responsiveness safely lowers perioperative cardiovascular risk.
Calderaro, Daniela; Pastana, Adriana Feio; Flores da Rocha, Tania Rubia; Yu, Pai Ching; Gualandro, Danielle Menosi; DeLuccia, Nelson; D' Amico, Elbio Antônio; Caramelli, Bruno.
J Vasc Surg
; 58(6): 1593-9, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24280324
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.
Vitamin C supplementation for the primary prevention of cardiovascular disease.
A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
Aspirin for Prevention of Cardiovascular Disease.